We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-5.73%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$36.6M
Cap. Flow
+$8.16M
Cap. Flow %
2.03%
Top 10 Hldgs %
74.52%
Holding
473
New
34
Increased
162
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
RWL icon
Invesco S&P 500 Revenue ETF
RWL
+$2M
2
IETC icon
iShares US Tech Independence Focused ETF
IETC
+$1.37M
3
SMH icon
VanEck Semiconductor ETF
SMH
+$950K
4
IYJ icon
iShares US Industrials ETF
IYJ
+$925K
5
IYG icon
iShares US Financial Services ETF
IYG
+$639K

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$168K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$122K
3
XSMO icon
Invesco S&P SmallCap Momentum ETF
XSMO
+$103K
4
SCHW
Charles Schwab
SCHW
+$99.3K
5
JNJ icon
Johnson & Johnson
JNJ
+$97.6K

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Consumer Staples 5.36%
3 Consumer Discretionary 4.81%
4 Financials 2.43%
5 Communication Services 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
226
Becton Dickinson
BDX
$48.7B
$9.67K ﹤0.01%
47
– –
MFA
227
MFA Financial
MFA
$933M
$9.53K ﹤0.01%
1,105
+35
+3% +$366
FNX icon
228
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
$9.52K ﹤0.01%
94
+1
+1% +$115
SKYX icon
229
SKYX Platforms
SKYX
$164M
$9.49K ﹤0.01%
10,000
– –
FCX icon
230
Freeport-McMoran
FCX
$97.5B
$9.46K ﹤0.01%
280
– –
XLK icon
231
State Street Technology Select Sector SPDR ETF
XLK
$124B
$9.42K ﹤0.01%
94
– –
SIRI icon
232
SiriusXM
SIRI
$10.1B
$9.25K ﹤0.01%
447
+5
+1% +$118
FYX icon
233
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.4B
$9.25K ﹤0.01%
110
– –
WBA
234
DELISTED
Walgreens Boots Alliance
WBA
$9.11K ﹤0.01%
835
– –
F icon
235
Ford
F
$55.7B
$8.96K ﹤0.01%
923
+723
+362% +$7.06K
KDP icon
236
Keurig Dr Pepper
KDP
$40.8B
$8.87K ﹤0.01%
248
+3
+1% +$97
GLW icon
237
Corning
GLW
$143B
$8.86K ﹤0.01%
213
– –
PFE icon
238
Pfizer
PFE
$153B
$8.8K ﹤0.01%
398
+6
+2% +$157
SLYV icon
239
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
$8.78K ﹤0.01%
124
+10
+9% +$848
KLAC icon
240
KLA
KLAC
$259B
$8.73K ﹤0.01%
130
– –
NXPI icon
241
NXP Semiconductors
NXPI
$60.4B
$8.53K ﹤0.01%
50
– –
SBS icon
242
Sabesp
SBS
$18.7B
$7.92K ﹤0.01%
2,202
– –
BBWI icon
243
Bath & Body Works
BBWI
$4.1B
$7.79K ﹤0.01%
272
+2
+0.7% +$71
BP icon
244
BP
BP
$107B
$7.61K ﹤0.01%
283
-275
-49% -$8.98K
ACGL icon
245
Arch Capital
ACGL
$33.6B
$7.34K ﹤0.01%
79
– –
INTU icon
246
Intuit
INTU
$89B
$7.18K ﹤0.01%
12
– –
MET icon
247
MetLife
MET
$62.4B
$7.17K ﹤0.01%
98
-215
-69% -$17.9K
AWK icon
248
American Water Works
AWK
$26.9B
$7.14K ﹤0.01%
+48
New +$6.32K
BMY icon
249
Bristol-Myers Squibb
BMY
$132B
$7K ﹤0.01%
136
+1
+0.7% +$58
HCA icon
250
HCA Healthcare
HCA
$89.5B
$6.91K ﹤0.01%
20
– –
8 9
10
11 12

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return

Kozak & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Kozak & Associates held 473 positions worth $401M, down 8.4% from $437M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kozak & Associates's Q1 2025 filing shows 34 new, 162 increased, 52 reduced and 17 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 324 shares worth $104K. The largest sale was Block Inc, an estimated $168K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Kozak & Associates's largest Q1 2025 buy was Madrigal Pharmaceuticals: 324 shares worth $104K.
  • Kozak & Associates added most to Invesco S&P 500 Revenue ETF in Q1 2025, an estimated $2M increase.
  • Kozak & Associates's biggest Q1 2025 reduction was Block Inc, cutting an estimated $168K.
  • Kozak & Associates fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, selling an estimated $44.8K.
  • Kozak & Associates's ten largest holdings make up 75% of its $401M portfolio in Q1 2025.
  • Kozak & Associates opened 34 new positions and closed 17 in Q1 2025.
  • Kozak & Associates's portfolio value fell 8.4% quarter-over-quarter to $401M.

Based on Kozak & Associates's 13F filing for Q1 2025, filed 15 Apr 2025.